Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Pharma
Viatris, Mapi's long-acting MS drug rebuffed by FDA
Viatris likely just lost one of its top product debuts for 2024, thanks to an FDA rejection of a new version of a popular multiple sclerosis drug.
Fraiser Kansteiner
Mar 11, 2024 11:11am
Biogen CEO plots turnaround after 'weak' 2023 performance
Feb 13, 2024 11:28am
Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda
Jan 11, 2024 1:15pm
Big Pharma reworks China strategy, and job cuts are part of it
Dec 22, 2023 8:22am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
Novartis puts ‘Sopranos’ actor in TV spot for MS drug Kesimpta
Dec 11, 2023 5:00am